May 24, 2011 -- Brisk walking may help men diagnosed with early-stage prostate cancer reduce their risk of progression of the disease, according to a new study.
Researchers at the University of California, San Francisco and the Harvard School of Public Health followed 1,455 men who had been diagnosed with early-stage prostate cancer.
The study shows that survivors who walk at a pace of at least 3 miles per hour for three hours or more per week were 57% less likely to develop the biochemical markers of cancer recurrence or to need a second round of treatment for their disease.
"The important point was the intensity of the activity," Erin Richman, ScD, a post-doctoral fellow at University of California, San Francisco, says in a news release. "The walking had to be brisk for men to experience a benefit."
She says the results of the study suggest a way for men who have prostate cancer to do something to improve their prognosis and stay well.
The study is published in the June 1 edition of Cancer Research.
Another study published earlier this year by June Chan, ScD, of University of California, San Francisco, along with researchers at Harvard, also showed that physical activity after diagnosis seemed to reduce disease-related death in a distinct group of men with prostate cancer.
The new study supports that finding and was the first to focus on the effect of exercise after diagnosis on early indications of progression of the disease, such as a rise in prostate-specific antigen (PSA) blood levels.
"Our work suggests that vigorous physical activity or brisk walking can have a benefit at the earlier stages of the disease," says Chan in the news release.
The participants in the study were a subset of a larger group of 14,000 men with prostate cancer enrolled in a long-term, nationwide prostate cancer registry project, known as the Cancer of the Prostate Strategic Urologic Research Endeavor. It's led by Peter Carroll, MD, MPH, chair of the urology department at University of California, San Francisco and one of the study's authors.